| Profile | GDS5420 / 1560443_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 421.1 | 64 |
| GSM1296119 | B_lesional_pre-dose | 235.05 | 55 |
| GSM1296076 | C_lesional_pre-dose | 143.96 | 49 |
| GSM1296092 | D_lesional_pre-dose | 127.7 | 47 |
| GSM1296103 | E_lesional_pre-dose | 313.2 | 60 |
| GSM1296078 | F_lesional_pre-dose | 178.04 | 52 |
| GSM1296107 | G_lesional_pre-dose | 341.55 | 61 |
| GSM1296109 | H_lesional_pre-dose | 412.23 | 64 |
| GSM1296080 | I_lesional_pre-dose | 236.23 | 56 |
| GSM1296090 | J_lesional_pre-dose | 171.92 | 51 |
| GSM1296074 | K_lesional_pre-dose | 120.73 | 47 |
| GSM1296111 | L_lesional_pre-dose | 315.09 | 60 |
| GSM1296099 | M_lesional_pre-dose | 376.42 | 62 |
| GSM1296086 | O_lesional_pre-dose | 175.64 | 52 |
| GSM1296117 | P_lesional_pre-dose | 283.25 | 57 |
| GSM1296113 | Q_lesional_pre-dose | 501.79 | 67 |
| GSM1296096 | R_lesional_pre-dose | 451.19 | 66 |
| GSM1296105 | S_lesional_pre-dose | 297.71 | 58 |
| GSM1296098 | T_lesional_pre-dose | 556.96 | 69 |
| GSM1296101 | U_lesional_pre-dose | 472.39 | 66 |
| GSM1296121 | V_lesional_pre-dose | 333.46 | 61 |
| GSM1296088 | W_lesional_pre-dose | 229.16 | 55 |
| GSM1296082 | X_lesional_pre-dose | 225.97 | 56 |
| GSM1296115 | Y_lesional_pre-dose | 279.19 | 58 |
| GSM1296084 | Z_lesional_pre-dose | 316.35 | 60 |
| GSM1296072 | B_lesional_day8 | 329.67 | 60 |
| GSM1296069 | L_lesional_day8 | 374.3 | 62 |
| GSM1296071 | P_lesional_day8 | 364.5 | 61 |
| GSM1296070 | Y_lesional_day8 | 329.46 | 60 |
| GSM1296073 | V_lesional_day8 | 268.52 | 58 |
| GSM1296034 | A_lesional_day15 | 578.88 | 69 |
| GSM1296041 | G_lesional_day15 | 315.92 | 60 |
| GSM1296035 | R_lesional_day15 | 329.23 | 60 |
| GSM1296038 | U_lesional_day15 | 335.66 | 61 |
| GSM1296047 | B_lesional_day15 | 367.15 | 62 |
| GSM1296039 | E_lesional_day15 | 327.5 | 61 |
| GSM1296042 | H_lesional_day15 | 349.77 | 61 |
| GSM1296043 | L_lesional_day15 | 379.05 | 62 |
| GSM1296037 | M_lesional_day15 | 336.14 | 61 |
| GSM1296046 | P_lesional_day15 | 351.21 | 61 |
| GSM1296044 | Q_lesional_day15 | 393.15 | 63 |
| GSM1296045 | Y_lesional_day15 | 299.06 | 58 |
| GSM1296025 | C_lesional_day15 | 129.26 | 46 |
| GSM1296033 | D_lesional_day15 | 156.41 | 49 |
| GSM1296027 | I_lesional_day15 | 199.6 | 54 |
| GSM1296032 | J_lesional_day15 | 184.65 | 51 |
| GSM1296024 | K_lesional_day15 | 170.66 | 51 |
| GSM1296031 | W_lesional_day15 | 260.11 | 56 |
| GSM1296028 | X_lesional_day15 | 200.91 | 53 |
| GSM1296029 | Z_lesional_day15 | 252.91 | 56 |
| GSM1296026 | F_lesional_day15 | 104.04 | 43 |
| GSM1296030 | O_lesional_day15 | 122.29 | 47 |
| GSM1296040 | S_lesional_day15 | 340.07 | 61 |
| GSM1296036 | T_lesional_day15 | 409.53 | 64 |
| GSM1296048 | V_lesional_day15 | 277.84 | 58 |
| GSM1296059 | A_lesional_day43 | 311.09 | 60 |
| GSM1296066 | G_lesional_day43 | 320.43 | 60 |
| GSM1296060 | R_lesional_day43 | 334.99 | 61 |
| GSM1296063 | U_lesional_day43 | 314.12 | 60 |
| GSM1296064 | E_lesional_day43 | 317.29 | 61 |
| GSM1296067 | H_lesional_day43 | 485.03 | 66 |
| GSM1296062 | M_lesional_day43 | 455.06 | 66 |
| GSM1296068 | Q_lesional_day43 | 344.1 | 60 |
| GSM1296050 | C_lesional_day43 | 215.34 | 54 |
| GSM1296057 | D_lesional_day43 | 290.64 | 58 |
| GSM1296052 | I_lesional_day43 | 248.2 | 57 |
| GSM1296054 | J_lesional_day43 | 234.58 | 54 |
| GSM1296049 | K_lesional_day43 | 187.64 | 52 |
| GSM1296055 | W_lesional_day43 | 313.08 | 59 |
| GSM1296053 | X_lesional_day43 | 263.48 | 57 |
| GSM1296058 | Z_lesional_day43 | 307.79 | 60 |
| GSM1296051 | F_lesional_day43 | 184.14 | 52 |
| GSM1296056 | O_lesional_day43 | 280.4 | 59 |
| GSM1296065 | S_lesional_day43 | 251.44 | 56 |
| GSM1296061 | T_lesional_day43 | 504.56 | 67 |
| GSM1296095 | A_non-lesional_pre-dose | 279.32 | 58 |
| GSM1296120 | B_non-lesional_pre-dose | 337.83 | 61 |
| GSM1296077 | C_non-lesional_pre-dose | 103.2 | 43 |
| GSM1296093 | D_non-lesional_pre-dose | 255.46 | 55 |
| GSM1296104 | E_non-lesional_pre-dose | 326.62 | 61 |
| GSM1296079 | F_non-lesional_pre-dose | 200.77 | 53 |
| GSM1296108 | G_non-lesional_pre-dose | 369.17 | 62 |
| GSM1296110 | H_non-lesional_pre-dose | 410.41 | 63 |
| GSM1296081 | I_non-lesional_pre-dose | 99.55 | 43 |
| GSM1296091 | J_non-lesional_pre-dose | 148.79 | 49 |
| GSM1296075 | K_non-lesional_pre-dose | 104.19 | 43 |
| GSM1296112 | L_non-lesional_pre-dose | 439.97 | 65 |
| GSM1296100 | M_non-lesional_pre-dose | 449 | 65 |
| GSM1296087 | O_non-lesional_pre-dose | 73.05 | 39 |
| GSM1296118 | P_non-lesional_pre-dose | 423.69 | 64 |
| GSM1296114 | Q_non-lesional_pre-dose | 590.19 | 70 |
| GSM1296097 | R_non-lesional_pre-dose | 401.57 | 64 |
| GSM1296106 | S_non-lesional_pre-dose | 420.69 | 64 |
| GSM1296102 | U_non-lesional_pre-dose | 500.89 | 67 |
| GSM1296122 | V_non-lesional_pre-dose | 327.48 | 60 |
| GSM1296089 | W_non-lesional_pre-dose | 309.06 | 59 |
| GSM1296083 | X_non-lesional_pre-dose | 204.92 | 53 |
| GSM1296116 | Y_non-lesional_pre-dose | 382.21 | 62 |
| GSM1296085 | Z_non-lesional_pre-dose | 174.97 | 50 |